C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 307/56 (2006.01) A61K 31/34 (2006.01) A61K 31/44 (2006.01) A61K 31/47 (2006.01) A61K 31/695 (2006.01) C07D 307/58 (2006.01) C07D 307/64 (2006.01) C07D 405/12 (2006.01) C07F 7/10 (2006.01)
Patent
CA 2117381
(SEE FIGURE I) Compounds useful in inhibiting the biosynthesis of leukotrienes have structure (I), where M is hydrogen, a pharmaceutically acceptable cation, or a metabolically cleavable group, R4 is alkyl, cycloalkyl or -NR5R6, where R5 and R5 are hydrogen, alkyl cycloalkyl or alkanoyl, where A is a valence bond or is a straight or branched divalent alkylene group of from one to twelve carbon atoms, R2 and R3 are independently selected from hydrogen, straight or branched alkyl of from one to twelve carbon atoms, halogen, or trifluoroalkyl, and R1 is selected from phenoxy, phenylthio, 2-, 3-, or 4-pyridyloxy, 1-, or 2- naph-thyloxy, or 2-, 4-, 5-, or 8-quinolytoxy all optionally substituted with alkyl, haloalkyl, alkoxy, hydroxy or halogen.
Bhatia Pramily
Brooks Dee W.
Craig Richard A.
Stewart Andrew O.
Abbott Laboratories
Swabey Ogilvy Renault
LandOfFree
N-substituted-furylalkenyl hydroxamic acid and n-hydroxyurea... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-substituted-furylalkenyl hydroxamic acid and n-hydroxyurea..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-substituted-furylalkenyl hydroxamic acid and n-hydroxyurea... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1992163